0.28 USD
▼-0.04-13.08%
盘后 0.29 +1.78%
2026-11-20
市值
$1.71M
市盈率
—
EPS
-0.14
股息率
—
52 周区间
0.28 – 1.60
成交量
24.25K
Beta
4.87
目标价
—
52W 低 0.2852W 高 1.60
价格走势
公司简介
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; ...